| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |